These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30941983)

  • 1. Clinicopathological factors influencing the prognosis of cervical cancer.
    Gai J; Wang X; Meng Y; Xu Z; Kou M; Liu Y
    J BUON; 2019; 24(1):291-295. PubMed ID: 30941983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
    Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
    Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
    Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
    Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
    Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
    Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
    Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
    Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
    Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
    Sasano T; Mabuchi S; Kuroda H; Takahashi R; Kozasa K; Isohashi F; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2016 Mar; 26(3):528-33. PubMed ID: 26825839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
    Behtash N; Karimi Zarchi M; Deldar M
    Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative adjuvant therapy in early invasive cervical cancer patients with histopathologic high-risk factors.
    Park TK; Kim SN; Kwon JY; Mo HJ
    Int J Gynecol Cancer; 2001; 11(6):475-82. PubMed ID: 11906552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
    Ng BH; Rozita A; Adlinda A; Lee WC; Wan Zamaniah W
    Asian Pac J Cancer Prev; 2015; 16(9):3827-33. PubMed ID: 25987044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer.
    Nishida T; Nakamura K; Haraga J; Ogawa C; Kusumoto T; Seki N; Masuyama H; Katayama N; Kanazawa S; Hiramatsu Y
    Int J Gynecol Cancer; 2015 Sep; 25(7):1306-14. PubMed ID: 26067860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.